• Accueil >
  • Publications >
  • 30P Protein signature associated with response and progression free survival in late-stage NSCLC patients treated with anti-PD-1 blockade

30P Protein signature associated with response and progression free survival in late-stage NSCLC patients treated with anti-PD-1 blockade

1 mars 2021Annals of Oncology

DOI : 10.1016/j.annonc.2021.01.044

Auteurs

E. Romano, K. Sklodowski, V. Dozio, A. Lanzós, K. Beeler